HOSPITAL UNIVERSITARIO RUBER
Departamento
![Foto de HOSPITAL UNIVERSITARIO RUBER](/img/noimage.png)
![Foto de National Cancer Center](/img/noimage_org.png)
National Cancer Center
Plainview, Estados UnidosPublicaciones en colaboración con investigadores/as de National Cancer Center (5)
2020
-
Trastuzumab deruxtecan in previously treated HER2-positive breast cancer
New England Journal of Medicine, Vol. 382, Núm. 7, pp. 610-621
2019
2017
-
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer
Breast Cancer Research and Treatment, Vol. 165, Núm. 3, pp. 601-609
2016
2015
-
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): A randomised, open-label, multicentre, phase 2 trial
The Lancet Oncology, Vol. 16, Núm. 16, pp. 1700-1710